BEND7P1

Across TCGA pan-cancer cohorts, BEND7P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of BEND7P1’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where BEND7P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BEND7P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

ESCA, CHOL, and THCA are the cancer types where BEND7P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BEND7P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	Female	All	+0.210	.030	2	view →
CHOL	All	All	+0.121	.037	1	view →
THCA	Male	All	−0.085	.038	1	view →
KIRC	All	II,III,IV	+0.032	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

BEND7P1–ESCA

Open the ESCA breakdown →